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The yeast Malassezia furfur, also known as Pityrosporum
orbiculare (ovale), is part of the normal microflora of
the human skin but has also been associated with
different skin diseases including atopic dermatitis.
More than 50% of atopic dermatitis patients have
positive skin test and specific IgE to M. furfur extracts;
however, the pathophysiologic role of these IgE-medi-
ated reactions in the development of the disease
remains unknown. The yeast is able to produce a wide
panel of IgE-binding proteins, variably recognized by
sera of individual patients. In order to assess the
contribution of individual components to the disease,
highly pure allergen preparations are required. We
have cloned M. furfur allergens from a cDNA library
displayed on the phage surface, sequenced the inserts
and produced recombinant proteins in Escherichia coli.
Phage displaying IgE-binding proteins were selectively
enriched from the library using IgE from a M. furfur-
M alassezia furfur (M. furfur) is a lipophilic yeastthat colonizes the skin of healthy individuals(Faergemann et al, 1983). Under the influence ofpredisposing factors, however, Malassezia yeastshave been implicated in the pathogenesis of a
number of skin diseases such as pityriasis (tinea) versicolor
(Faergemann, 1979) and seborrhoeic dermatitis (Faergemann et al,
1996). In recent years it has been suggested that M. furfur also plays
an important part in the pathogenesis of atopic dermatitis (AD) as
40–65% of patients with AD have positive skin tests or specific
IgE serology with M. furfur extracts (Kieffer et al, 1990; Nordvall
and Johansson, 1990; Rokugo et al, 1990; Ba¨ck et al, 1995). A
number of IgE-binding components are present in M. furfur
as shown by immunoblotting and the pattern of IgE-binding
components varies between individual patient sera and between
extracts (Jensen-Jarolim et al, 1992; Zargari et al, 1995; Lintu et al,
1997). In order to determine the importance of individual IgE-
binding components it is desirable to obtain pure allergen prepara-
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sensitized atopic dermatitis patient as a ligand. We
were able to identify five different inserts coding for
IgE-binding polypeptides. Three of the sequenced
cDNA encode incomplete gene products with molecu-
lar masses of 21.3 kDa (MF 7), 14.4 kDa (MF 8), and
9.7 kDa (MF 9), respectively, having no sequence
similarity to known proteins. The other two cDNA
encode allergens of 18.2 kDa (Mal f 5) and 17.2 kDa
(Mal f 6). Mal f 5 shows significant homology to M. furfur
allergens Mal f 2, Mal f 3 and an Aspergillus fumigatus
allergen Asp f 3. Mal f 6 has significant homology with
cyclophilin. All of the recombinant polypeptides were
capable of binding serum IgE from atopic dermatitis
patients in immunoblotting experiments. The avail-
ability of pure recombinant M. furfur allergens will allow
the careful investigation of the role of IgE-binding
proteins in atopic dermatitis. Key words: allergy/atopic
dermatitis/Pityrosporum orbiculare. J Invest Dermatol
113:156–161, 1999
tions free from contaminating proteins. Recent years have seen the
development of DNA technology, making the production of pure
recombinant allergens in large quantities a relatively straightforward
task compared with purifying allergens from a crude extract of the
natural allergen source. Standardized mixtures of well characterized
recombinant allergens have the potential to eliminate the problems
of reproducibility associated with crude allergen extracts which are
commonly used in diagnosis of allergy and to increase significantly
specificity and sensitivity (Crameri et al, 1998). In order to have a
reliable diagnostic tool, however, a large panel of allergens is
required. So far only three M. furfur allergens designated Mal f 1,
Mal f 2, and Mal f 3 have been cloned and sequenced (Schmidt
et al, 1997; Yasueda et al, 1998). Mal f 1 is a cell wall protein that
does not show sequence similarity to other proteins (Schmidt et al,
1997; Zargari et al, 1997). Mal f 2 and Mal f 3 on the other hand
show sequence homology to each other and to other fungal
allergens such as Asp f 3 from Aspergillus fumigatus (Hemmann et al,
1997) and peroxisomal membrane proteins A and B (PMPA and
PMPB) from Candida boidinii (Garrard and Goodman, 1989).
We have employed a strategy that allows the expression and
display of complex cDNA libraries on the surface of filamentous
phage (Crameri et al, 1994) to clone additional allergens from
M. furfur. The main advantage of this strategy, which is based on
the pJuFo cloning system, over more commonly used λ phage
cloning systems is that the cDNA expression products of pJuFo are
expressed covalently attached to the phage surface. This allows
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selective enrichment of phage displaying proteins able to interact
with a ligand (IgE) immobilized on a solid support whereas
noninteracting phage remain in the liquid phase. Several allergens
from A. fumigatus have been successfully cloned using the pJuFo
system (Crameri and Blaser, 1996). Here we report the application
of the pJuFo cloning system to enrich allergen encoding cDNA
from a M. furfur phage surface display library. Five new M. furfur
allergens have been isolated, sequenced, and partially characterized.
MATERIALS AND METHODS
Growth of M. furfur and mRNA isolation M. furfur from the American
Type Culture Collection (no. 43132) was cultured on glycerol monostear-
ate/olive oil (Go) medium for 2 d at 37°C (Zargari et al, 1994). Isolation
of mRNA from 2 d old M. furfur was performed using a commercial kit
(Poly A Tract System 1000, Promega, Madison, WI) according to the
manufacturer’s instructions. The oligo(dT) selected mRNA was precipitated
with isopropanol, dissolved in distilled water, and stored at –70°C.
cDNA synthesis The cDNA was synthesized using the Marathon cDNA
amplification kit (Clontech, Palo Alto, CA), with modified cDNA synthesis
primer, adaptor, and PCR primers, allowing the unidirectional insertion
of PCR products into the XbaI/Asp718 restricted pJuFo vector (Crameri
et al, 1994). All oligonucleotides were synthesized by Medprobe (Oslo,
Norway) unless stated. First- and second-strand synthesis were performed
according to the manufacturers’ instructions starting from 1 µg of poly(dT)
selected mRNA with the exception that the cDNA synthesis primer was
exchanged for (59-GCTGCCTCTGCGTCGACATCTGACAAAGCT-
TGGTACCTTTTTTTTTTTTTTTTTNN-39).
The next step was to ligate an adaptor containing an XbaI restriction
site to the double-stranded cDNA. The adaptor was generated by annealing
adaptor oligonucleotide 1 (59-CTAATACGACTCACTATAGGGCTCT-
AGAGCGGCCGCCCGGGCAGGT-39) and daptor oligonucleotide 2
(59-PO3-ACCTGCCC-NH2–39) (Cybergene, Stockholm, Sweden) in
equal concentrations (10 µM). Thereafter, 5 µl of double-stranded cDNA,
2 µl adaptor (10 µM), 2 µl ligation buffer (53) and 1 µl T4 DNA ligase
(1 unit per µl) were mixed, ligated at 16°C overnight, and finally heated
to 70°C for 5 min to inactivate the ligase.
To amplify the cDNA using PCR the anchor ligated cDNA was first
diluted in Tricine-EDTA buffer (1/100). PCR reactions were performed
in a final volume of 50 µl. KlenTaq PCR reaction buffer containing 5 µl
diluted anchor ligated cDNA, 0.2 µM 59-primer (59-CCATCCTAA-
TACGACTCACTATAGGGC-39), 0.2 µM 39-primer (59-GCTGCC-
TCTGCG-TCGACATCTGACA-39), 20 µM dNTPs, and 1 µl Advantage
KlenTaq Polymerase mix was heated to 94°C for 8 min followed by 25
cycles of 94°C (1 min), 57°C (2 min), 72°C (2 min 30 s), and a final
extension at 72°C (10 min). After purification by phenol chloroform
extraction and ethanol precipitation PCR products were digested with
XbaI and Asp718 in a 50 µl reaction. The digested cDNA was separated
on a 1% Tris-acetate/EDTA agarose gel and products exceeding 300 bp
in length were enriched for on NA45 DEAE membrane (Schleicher and
Schuell, Dassel, Germany) as described (Ausubel et al 1998).
Construction of library in pJuFo Two micrograms of pJuFo phagemid
DNA (XbaI/Asp718 digested) was ligated overnight using T4 DNA ligase
(Boehringer Mannheim, Germany) with 1.5 µg of cDNA in a 40 µl
reaction. The ligation was phenol/chloroform/isoamyl alcohol and chloro-
form extracted followed by ethanol precipitation. The pellet was resus-
pended in 5 µl water and transformed into Escherichia coli strain XL2-Blue
(Stratagene, La Jolla, CA) by electroporation. The transformed cells were
grown at 37°C in 2.5 ml SOC medium (Sambrook et al, 1989) with
shaking for 1 h and then the volume was made to 10 ml with SOB
medium (Sambrook et al, 1989) containing 20 µg ampicillin per ml and
10 µg tetracycline per ml. An aliquot (100 µl) was taken, serially diluted
and plated on to L-agar plates containing 100 µg ampicillin per ml in
order to determine the primary size of the library. The remainder of the
culture was incubated with shaking at 37°C for a further hour and processed
as described to generate a phage surface display library (Barbas and Lerner,
1991). The next day the cells were harvested and plasmid DNA was
prepared. PEG 8000 (4%) and NaCl (3%) were added to precipitate the
phage. The phage were pelleted by centrifugation at 8000 3 g for 20 min
and resuspended in 1 ml Tris-buffered saline (5 mM Tris–HCl pH 7.5,
150 mM NaCl) containing 1% bovine serum albumin, titered, aliquoted,
and stored at –20°C.
Selection of sera The serum used in the biopanning was from an AD
patient (AD1) with a radioallergosorbent test (RAST) to M. furfur of 43 kU
per liter and total IgE of 5500 kU per liter. This serum was positive in
immunoblotting and contained IgE recognizing most of the major allergens
from M. furfur. Twenty-four additional sera chosen for further immuno-
blotting experiments were from patients with AD and a M. furfur RAST
class ù 2 (ù 0.7 kU per liter) and total IgE levels ranging from 98 to
5500 kU per liter (median 1470 kU per liter).
For negative controls five sera with total IgE levels ranging from 530
to 1100 kU per liter (median 740 kU per liter) but RAST class 0 and
immunoblot negative to M. furfur whole extract were used. A myeloma
IgE (DES) diluted in cord serum to 16700 kU per liter was used as an
additional negative control (Magnusson et al, 1986).
Isolation and analysis of phage displaying IgE-binding proteins
(Biopanning) One microgram of mouse anti-human IgE monoclonal
antibody designated CGM9 (Magnusson et al, 1986) in 100 µl was coated
on to polystyrene microtiter wells overnight at 20°C. The coated wells
were extensively washed and 100 µl of serum from AD1 was added to
each monoclonal antibody coated well and incubated overnight at 20°C.
After washing, 100 µl of the phage library in Tris-buffered saline 1%
bovine serum albumin was added, the plate was incubated at 20°C for 2 h,
and then washed extensively to remove unbound phage. The bound phage
was eluted with 75 µl 0.1 M HCl (adjusted to pH 2.2 with solid glycine)
containing 1% bovine serum albumin and immediately neutralized by the
addition of 4.5 µl 2 M Tris base. This elution step was repeated once, the
eluates pooled and used to infect 4 ml of freshly grown XL2-Blue cells
for 15 min. The volume was increased to 10 ml with TYP broth (16 g
Bacto-tryptone, 16 g Bacto-yeast extract, 5 g NaCl, 2.5 g K2HPO4, per
liter) containing 20 µg per ml ampicillin 10 µg per ml tetracycline, an
aliquot removed and serial dilutions were plated on to L-agar containing
100 µg per ml ampicillin in order to determine the number of phage
eluted. The infected XL-2 Blue culture was used to generate phage for a
further round of selection as described (Barbas and Lerner, 1991; Crameri
and Suter, 1993). The biopanning procedure was repeated four times.
Individual colonies from each round of biopanning were cultured and
plasmids prepared using QIAprep spin plasmid mini prep kit (Qiagen,
Hilden, Germany) to monitor selective enrichment by restriction analysis.
Sequencing and sequence analysis All sequencing was performed on
an ABI prism 377 sequencer using the dRhodamine terminator cycle
sequencing kit (Perkin Elmer, Foster City, CA) following the manufacturer’s
instructions. The cDNA sequences were initially analyzed from the
BCM Search Launcher using a WU-BLASTX 2.0 search of the NCBI
nonredundant (nr) protein database. Sequence alignments were performed
using the Clustal method in MEGALIGN (DNASTAR, Madison, WI).
Subcloning of selected cDNA into expression vector pET 17b The
coding regions of the cDNA of the different allergens were amplified from
the appropriate phagemid DNA using PCR with Pfu DNA polymerase
(Stratagene) in a standard reaction. The primer pairs used for amplification
of the five cDNA encoding IgE-binding polypeptides are shown (Table I).
The 39-primers contain a stop codon and a HindIII restriction site behind
a His6-tag fused to the 39 ends of the coding regions. The 59-primers
contain a NdeI restriction site, allowing introduction of the PCR products
into the NdeI/HindIII digested plasmid pET17b (Novagen, Madison, WI).
Ligations were transformed into E. coli XL-2 by electroporation, plasmid
prepared from single transformants and correct constructs verified by
restriction digest and DNA sequencing. Correct constructs were trans-
formed by electroporation into the E. coli expression strain BL21 DE3
pLysS (Novagen) to produce C-terminal His6-tagged fusion proteins.
Expression and purification of recombinant proteins Overnight
cultures of BL21 DE3 pLysS containing the recombinant pET plasmids
were diluted 50-fold in prewarmed LB-medium (100 ml) containing
ampicillin (100 µg per ml), chloramphenicol (30 µg per ml) and grown to
an A600 of 0.6 at 37°C. Expression of the recombinant proteins was
induced by the addition of 0.4 mM isopropyl-β-D thiogalactoside and
incubation was continued for a further 2 h. The induced cells were
harvested, resuspended in 5 ml 20 mM Tris–HCl, 200 mM NaCl, pH 7.4,
frozen, and thawed. The thawed cells were disrupted by sonication and
cleared by centrifugation (10 min, 14,000 3 g). The supernatant was
removed (soluble fraction of E. coli lysate) and stored at 4°C until
purification. The pellets (inclusion bodies) were washed and solubilized
using urea as described (Sambrook et al, 1989). Purification of the
recombinant proteins either from the soluble fraction of the E. coli lysate
or the solubilized inclusion bodies was performed using TALON metal
affinity resin (Clontech) according to the instructions of the manufacturer
and eluted in phosphate-buffered saline containing 100 mM imidazole
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Table I. Oligonucleotides used for the amplification of cDNA coding for the IgE binding proteins
cDNA 59 PCR primer (59–39) 39 PCR primer (59–39)
Mal f 5 CACCATATGTCTGCTACTACCGGTTCTC CACAAGCTTAATGATGATGATGATGATGGAGCTGCGCCAGCACCGCG
Mal f 6 CACCATATGTCTAACGTTTTCTTCGACATTACC CACAAGCTTAATGATGATGATGATGATGGCACACACCGCACTTGGCGA
MF 7 CACCATATGGCTGTCTCGGCCTCGCCCA CACAAGCTTAATGATGATGATGATGATGGGCGTTCTTCTTGAGATTGAGC
MF 8 CACCATATGCGTCACCGCGAGAGCATTGG CACAAGCTTAATGATGATGATGATGATGGCAGTATTGGCCAGGGATGAC
MF 9 CACCATATGGTGCAGCCCATCATTGAGAAGG CACAAGCTTAATGATGATGATGATGATGCTGAGAGAGAGGCAGGCCAC
Table II. Main characteristics of phage displaying IgE binding proteins which were isolated from a M. furfur phage surface
display library by selective enrichment
Amount of pure
Number of RAST positive recombinant protein Preliminary designation
Phage (n) out of 32 Length of cDNA insert Molecular mass of sera (and %) recognising produced per litre of and (EMBL accession
checked and (ORF) base pairs deduced protein (kDa) the recombinant protein E. coli culture (mg) number)
2 572 (516) 18.2 12 (48%) 60 Mal f 5c (AJ011955)
2 571 (486) 17.2 12 (48%) 9 Mal f 6c (AJ011956)
11a 754 (561) 21.3 12 (48%) 12 MF 7d (AJ011957)
1 614 (396) 14.4 6 (24%) 8 MF 8d (AJ011958)
13a 343 (261) 9.7b 5 (20%) 14 MF 9d (AJ011959)
aOverlapping clones found, the longest is reported.
bThe molecular mass of the peptide expressed on phage surface is given since the real size of the protein is unknown.
cDesignated according to the WHO/IUIS Allergen Nomenclature Subcommitee recommendation (King et al, 1994; Larsen and Lowenstein 1996).
dOfficial allergen nomenclature not yet approved.
(Sigma, St Louis, MO). Protein concentrations of rMal f 5, rMal f 6, rMF
7, and rMF 8 were calculated using the extinction coefficients of each
recombinant protein and measuring absorbance at 280 nm. The protein
concentration of rMF 9 was estimated from Coomassie blue stained gels
in comparison with the other recombinant proteins.
Immunoblotting of recombinant allergens Purified proteins were
electrophoresed on 15% sodium dodecyl sulfate polyacrylamide gels and
either stained with Coomassie brilliant blue or blotted on to polyvinylidene
fluoride membranes (Millipore, Bedford, MA). The membranes were cut
into strips and incubated with sera from AD patients or controls diluted
1:6 in phosphate-buffered saline containing 0.2% bovine serum albumin,
0.1% Tween 20. Blotting and detection of IgE-binding proteins was
performed as previously described (Zargari et al, 1994).
RESULTS
Construction of phage display cDNA library The primary
size of the pJuFo phage display cDNA library of M. furfur was
1 3 107 independent clones. After amplification with helper phage,
a stock with a titer of 5 3 108 cfu per µl was obtained. Sixteen
individual cfu were picked, plasmid was prepared, and digested
with XbaI and KpnI. Twelve of the colonies (75%) had different
inserts ranging in size from 250 bp to 800 bp in length. This library
was used for selective enrichment of IgE-binding proteins.
Selective enrichment and characterization of human IgE-
binding clones The M. furfur phage display library was subjected
to five rounds of biopanning against serum IgE from patient AD1.
Single clones are expected to be represented several times in the
phagemid population selected as a consequence of amplification
and enrichment of the IgE-binding clones during consecutive
rounds of biopanning (Table II). After the fifth round of bio-
panning, 32 individual bacterial colonies containing pJuFo derived
phagemids were picked, the phagemid DNA prepared and the
cDNA inserts sequenced. Analysis of the cDNA inserts showed
that there were sequences derived from five different cDNA
designated Mal f 5, Mal f 6, and MF 7–9 (Table II) present in
these 32 clones. Three of the 32 selected clones had no insert
when digested with restriction enzymes XbaI and KpnI and were
not analyzed further.
Homology searches of the NCBI nr protein database revealed
that Mal f 5 showed significant sequence similarity with the M. furfur
allergens Mal f 2 and Mal f 3 and also the A. fumigatus allergen Asp
f 3 (Fig 1). Mal f 6 showed highest sequence similarity to cyclophilin
from Schizosaccharomyces pombe (Fig 2). The three other inserts
encoding MF 7 (754 bp) with an open-reading frame of 561 bp
predicting a polypeptide of 21.3 kDa, MF 8 (614 bp) with an
open-reading frame of 396 bp encoding a protein of 14.4 kDa and
MF 9 (343 bp) with an open-reading frame of 261 bp predicting
a small polypeptide of 9.7 kDa did not show significant similarity
with sequences in the databases at the time of the search. It should
be noted that MF 7, MF 8, and MF 9 are probably not full length
cDNA (see Discussion).
Production of recombinant proteins The different cDNA
encoding for the potential allergens were subcloned into the
expression plasmid pET 17b and the proteins were expressed as
His6-tagged proteins. Three of the proteins rMal f 5, rMal f 6, and
rMF 9 were present mainly in the soluble fraction of the E. coli
lysates. The other proteins rMF 7 and rMF 8 were mainly in
inclusion bodies which had to be solubilized in urea before
purification. Production yields varied between 8 mg per liter and
60 mg per liter culture depending on the cDNA insert (Table II).
The affinity purified recombinant proteins were virtually pure as
shown by sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis and Coomassie blue staining (Fig 3). The apparent
molecular masses of Mal f 5, 6, and MF 7 were in good agreement
with the calculated molecular masses of 19 kDa, 18 kDa, and
22 kDa, respectively, for the His6-tagged proteins. MF 9 and
especially MF 8, however, showed a considerable discrepancy
between molecular mass estimated from the gel of 15 kDa and
24 kDa, respectively (Figs 3 and 4) and the calculated masses of
11 kDa and 15.5 kDa for the His6 fusions. Re-sequencing of the
inserts carried by the strains used for protein production showed
open-reading frames encoding proteins of 11 and 15.5 kDa and
therefore the discrepancy between calculated and observed molecu-
lar masses is likely to be due to an anomalous migration of the
proteins on gels as has been described also for other proteins
(Takano et al, 1988).
IgE immunoblot analysis of recombinant proteins Sera from
25 patients with positive RAST values to M. furfur whole extract
(Table II) and five control sera negative in RAST to M. furfur
were tested in immunoblotting to see if they contained IgE
recognizing the five recombinant proteins. All of the recombinant
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Figure 1. Multiple sequence alignment (Clustal)
of Mal f 5 with the Mal f 2, Mal f 3, and Asp f 3
allergens. Amino acid residues which are completely
conserved between the four proteins are boxed and
the consensus is shown.
Figure 2. Alignment of Mal f 6 with cyclophilin
from S. pombe. Amino acid residues which are
identical in the two proteins are boxed.
proteins were recognized by IgE in some of the M. furfur RAST
positive sera (Fig 4). In each preparation only one band was visible
with the exception of Mal f 5 demonstrating that the proteins were
free from IgE-binding contaminants. The extra band in rMal f 5
lane is double the size of the monomer suggesting that it may be
a covalently linked dimer (see Discussion) because of incomplete
reduction of the sample prior to electrophoresis. None of the
proteins were recognized by IgE in the five RAST negative sera
or by myeloma IgE (data not shown).
DISCUSSION
AD is a chronic inflammatory skin disease that has increased in
incidence in recent years (Leung, 1997). A knowledge of the agents
contributing to the disease is needed in order to diagnose and treat
the disease accurately. Anti-M. furfur IgE reactivity is closely
associated with AD and M. furfur contains a number of allergenic
components, some of which, are expressed on the cell surface
(Zargari et al, 1997) and can be released into the growth media
(unpublished data). Other allergens may be released from the yeast
by the actions of cell-mediated defence (Romani and Howard,
1995). Here we have described the cloning and expression of five
new allergens from M. furfur.
Mal f 5 has a monomer molecular mass of 18.2 kDa and shows
similarity to the recently cloned M. furfur allergens Mal f 2 (57%
identity) and Mal f 3 (58% identity) as well as the A. fumigatus
allergen Asp f 3 (43% identity). It will be interesting to study if
Figure 3. Sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis analysis of purified recombinant allergens. The molecular
mass markers (lane 1, kDa), rMal f 5 (lane 2), rMal f 6 (lane 3), rMF 7 (lane
4), rMF 8 (lane 5), and rMF 9 (lane 6) were denatured by boiling in reducing
conditions, separated by 15% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis, and stained with Coomassie brilliant blue. The amount of
each recombinant allergen loaded was 1 µg per mm of gel.
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Figure 4. Immunoblot analysis of purified recombinant allergens.
Results from two M. furfur RAST-positive sera are shown for each protein:
rMal f 5, rMal f 6, rMF 7, rMF 8, and rMF 9 (lanes 1–5, respectively).
Full results are summarized in Table II.
there is IgE cross-reactivity between the homologous allergens.
Mal f 2 and f 3 have been shown to be homodimeric proteins in
M. furfur (Yasueda et al, 1998) and it is highly plausible that Mal f 5
is also a homodimer covalently linked by a disulfide bridge at the
conserved cysteine residues at position 29 or 59. Whether the
sequence differences in Mal f 5 as compared with the Mal f 2 and
f 3 allergens are due to strain variability or to isoallergen encoding
sequences in the M. furfur strain used remains to be determined.
Mal f 6 has a calculated molecular mass of 17.2 kDa and shows
high sequence similarity (82% identity) to cyclophilin from S. pombe.
Although to our knowledge S. pombe cyclophilin has not been
implicated in allergic disease, cyclophilin (Psi c 2) from the fungus
Psilocybe cubensis, which has 78% identity with S. pombe cyclophilin,
has been reported to be a major allergen (Horner et al, 1995). We
were unable to locate the sequence of P. cubensis cyclophilin in the
databases to make a direct comparison with M. furfur cyclophilin.
Cyclophilin has also recently been reported to be an allergen
produced by A. fumigatus (Crameri, 1999) and shares 71% sequence
identity to Mal f 6. Moreover, both Mal f 5 and Mal f 6 show
cross-reactivity to the homologous allergens rAsp f 3 (Hemmann
et al, 1997) and rAsp f 11 (cyclophilin) of A. fumigatus (unpub-
lished data).
MF 7, MF 8, and MF 9 show no sequence similarity with
known proteins and are hence novel allergens. Owing to any lack
of similarity to known proteins we must consider the possibility
that the cDNA clones coding for MF 7 and MF 8 may not be full
length. MF 9 is definitely not full length as it lacks any ATG
codons but ATG codons at amino acids 47 and 15 in MF 7 and
MF 8, respectively, are possible translational start codons. The
polypeptides encoded by these clones do however, contain at
least some IgE-binding epitopes of the full length proteins as
demonstrated by immunoblot analysis (Fig 4).
All of the proteins have been expressed as recombinant proteins
in E. coli and have been shown to be recognized by IgE (Table II).
Only six of the 25 (24%) RAST positive sera tested did not contain
IgE recognizing at least one of the recombinant allergens in
immunoblotting; therefore, the sensitivity for the diagnosis of
M. furfur sensitization reached with the panel of recombinant
allergens reported here is reasonably good. These allergens combined
with cloning and expression of additional allergens, however, which
are certainly present in the enriched library, together with the
already cloned rMal f 1 (Schmidt et al, 1997), Mal f 2, and Mal f
3 (Yasueda et al, 1998) will help increase the sensitivity of the
diagnosis based on recombinant allergens and perhaps allow the
substitution of M. furfur extracts with perfectly standardizable
reagents. Allergy testing in vivo and in vitro is still mainly based
on allergen preparations consisting of heterogeneous mixtures of
proteins which can vary in allergen content (Zargari et al, 1995)
and are often difficult to standardize (Valenta et al, 1998). A defined
panel of pure standardized allergens has many advantages over
crude extracts in the diagnosis of fungal allergy as demonstrated for
A. fumigatus (Crameri, 1998), may have applications in allergen
specific immunotherapy (Valenta et al, 1998), and will certainly
contribute to elucidating the molecular basis of IgE cross-reactivity
observed between different organisms (Hemmann et al, 1997). A
number of T cell lines and clones from AD patients specific for
M. furfur which show a Th2-like cytokine production profile have
been established (Tengvall Linder et al, 1996, 1998). With the
availability of the recombinant M. furfur allergens it is now possible
to evaluate the T cell reactivity of AD patients to individual well
defined allergen components. The panel of M. furfur allergens now
available will be used as a tool to study the role of IgE-binding
proteins in the pathogenesis of AD.
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